ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,320Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 4853

$1.83M Total Retail Price of All Prescriptions

Rank: 30 out of 4853

626 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 626 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

26% of this provider’s 626 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
NAMENDA 1,092 1,023 74 1 34
LEVOTHYROXINE SODIUM 1,031 818 152 2 1
FUROSEMIDE 881 803 103 3 9
HYDROCODONE-ACETAMINOPHEN 765 612 146 S3 4 3
SIMVASTATIN 751 535 126 5 4
ATORVASTATIN CALCIUM 621 556 115 6 7
TRAZODONE HCL 619 554 97 7 40
EXELON 611 576 81 8 106
AMLODIPINE BESYLATE 578 540 92 9 5
DONEPEZIL HCL 488 445 73 10 35
OMEPRAZOLE 428 359 81 11 8
METFORMIN HCL 408 329 69 12 6
METOPROLOL SUCCINATE 338 234 66 13 15
LISINOPRIL 331 291 66 14 2
SERTRALINE HCL 330 273 40 15 25
CLOPIDOGREL 323 280 48 16 19
CITALOPRAM HBR 300 295* 38 17 26
POTASSIUM CHLORIDE 282 254 52 18 16
DIVALPROEX SODIUM 280 257 41 19 97
CYMBALTA 277 272* 26 20 41
MIRTAZAPINE 272 267* 40 21 62
GABAPENTIN 237 183 38 22 13
METOPROLOL TARTRATE 235 194 40 23 11
LANTUS 233 209 36 24 59
ESCITALOPRAM OXALATE 216 174 33 25 50
QUETIAPINE FUMARATE 213 200 35 A 26 60
ABILIFY 210 147 15 A 27 125
ZOLPIDEM TARTRATE 204 154 47 28 22
ALPRAZOLAM 203 176 43 B 29 17
NUEDEXTA 197 197 17 30 218
ALENDRONATE SODIUM 194 181 26 31 30
OLANZAPINE 192 187* 30 A 32 127
LEVETIRACETAM 184 133 20 33 113
DIOVAN 182 136 18 34 45
LYRICA 181 162 20 35 61
LACTULOSE 179 152 32 36 110
NOVOLOG 178 149 32 37 135
LOSARTAN POTASSIUM 176 154 37 38 18
LOSARTAN-HYDROCHLOROTHIAZIDE 164 133 35 39 44
KLOR-CON M20 159 154* 28 40 104
TRAMADOL HCL 153 148* 44 41 14
CLONAZEPAM 146 119 24 B 42 52
LORAZEPAM 144 93 38 B 43 43
FLUTICASONE PROPIONATE 131 112 30 44 33
CRESTOR 130 91 30 45 23
TAMSULOSIN HCL 130 117 20 45 28
METFORMIN HCL ER 129 105 35 47 47
ROPINIROLE HCL 127 114 12 48 108
FAMOTIDINE* 127 109 22 48 89
AZITHROMYCIN 121 100 97 50 36
FENOFIBRATE* 118 81 13 51 56
MONTELUKAST SODIUM 114 82 16 52 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 68 31 53 21
WARFARIN SODIUM 108 103* 17 53 29
KLOR-CON M10 106 101* 18 55 149
PHENOBARBITAL 105 73 11 R 56 228
NITROGLYCERIN PATCH 102 <11 <11 57 208
HUMALOG 102 91 20 57 184
HYDROCHLOROTHIAZIDE 97 92* 23 59 12
PANTOPRAZOLE SODIUM 96 84 22 60 31
CARBIDOPA-LEVODOPA 94 82 12 61 136
NITROFURANTOIN MONO-MACRO 92 81 67 62 175
CARVEDILOL 91 86* 20 63 24
MELOXICAM 86 50 23 64 27
CIPROFLOXACIN HCL 82 63 67 65 48
JANUVIA 82 48 22 65 54
RANITIDINE HCL 81 76* 17 67 53
NEXIUM 81 59 22 67 20
ISOSORBIDE MONONITRATE ER 77 <11 <11 69 67
LANTUS SOLOSTAR 75 50 20 70 84
GLIMEPIRIDE 75 45 12 70 37
VENLAFAXINE HCL ER 74 45 13 72 114
NAMENDA XR 73 73 13 73 344
DIAZEPAM 72 29 24 B 74 101
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 55 59 75 70
ALLOPURINOL 69 55 15 76 38
CELEBREX 68 56 23 77 77
ADVAIR DISKUS 66 61* 20 78 65
CALCIUM ACETATE 66 43 11 78 369
PRAVASTATIN SODIUM 63 <11 <11 80 10
POLYETHYLENE GLYCOL 3350 63 47 14 80 98
EVISTA 61 <11 <11 82 119
NYSTATIN 61 39 20 82 161
IPRATROPIUM-ALBUTEROL 61 56* 29 82 166
PAROXETINE HCL 61 38 11 82 79
BD ULTRA-FINE PEN NEEDLE 60 47 24 86 126
BENZTROPINE MESYLATE 60 <11 <11 R 86 155
SPIRONOLACTONE 59 54* 23 88 76
LEVOFLOXACIN 58 53* 49 89 69
PROMETHAZINE HCL 58 53* 26 R 89 112
OXYBUTYNIN CHLORIDE ER 57 <11 <11 91 146
PIOGLITAZONE HCL 56 <11 <11 R 92 73
ARICEPT 55 <11 <11 93 340
CARBIDOPA-LEVODOPA-ENTACAPONE 55 <11 <11 93 547
TEMAZEPAM 54 <11 <11 B 95 82
RISPERIDONE 54 <11 <11 A 95 83
TRIAMCINOLONE ACETONIDE 54 <11 <11 95 117
PROAIR HFA 54 49* 18 95 58
VESICARE 53 48* 11 99 115
DIVALPROEX SODIUM ER 53 20 11 99 170
DIGOXIN 52 47* 13 101 147
CLONIDINE HCL 52 31 12 101 49
AMOXICILLIN 51 38 44 103 86
CYCLOBENZAPRINE HCL 51 32 19 R 103 68
FENOFIBRATE* 51 <11 <11 103 56
PHENYTOIN SODIUM EXTENDED 50 <11 <11 106 133
SPIRIVA 50 33 13 106 80
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.